Clinical Trials
552 trialsFulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
American Society of Clinical Oncology
TALES
University of California, San Francisco
OFSET
NRG Oncology
HEAL-ABC
NRG Oncology
Subito
The Netherlands Cancer Institute
Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer
Fudan University
NoLEEta
UNICANCER
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
Alliance for Clinical Trials in Oncology
DETE-BR
West China Hospital
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
ULTIMO
Cancer Research Antwerp
ADAPTcycle
West German Study Group
POWER II
University of Virginia
PRART
Weill Medical College of Cornell University
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
NRG Oncology
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
NRG Oncology
GIM10-CONSENT
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
ADAPT-TN-IV
West German Study Group
ADAPTela
West German Study Group
Relaxation for Women With Breast Cancer Undergoing Radiotherapy
M.D. Anderson Cancer Center
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NRG Oncology
Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
ABCD RT
NRG Oncology
DEBRA
NRG Oncology
Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
MEGA-TACT-BC3
Sun Yat-sen University
Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment
Institut Paoli-Calmettes
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
Alliance for Clinical Trials in Oncology
AMBITION
Japanese Foundation for Cancer Research
ECLECTIC
Institut Curie
MAPAM-01
Institut Claudius Regaud
Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy
Fudan University
CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon)
Fudan University
POWER
Karolinska Institutet
LOLIPOP
Monash University
OPTIMA-YOUNG
UNICANCER
PLANET
The Netherlands Cancer Institute
STEREO-SEIN
Gustave Roussy, Cancer Campus, Grand Paris
CRYSTAL
Franciscus Gasthuis & Vlietland (Hospital)
MNEMOSYNE
Centre Oscar Lambret
TSARINE
Centre Oscar Lambret
VITACAL
Institut du Cancer de Montpellier - Val d'Aurelle
MECCA
Sun Yat-sen University
CAPIcorn
West German Study Group
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Alliance for Clinical Trials in Oncology
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction
Memorial Sloan Kettering Cancer Center
PATINA
Alliance Foundation Trials, LLC.